A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:
Back to home » Top Stories » CROI 2010
17th Conference on Retroviruses and Opportunistic Infections
CROI 2010 17th Conference on Retroviruses and Opportunistic Infections
Moscone Center West
San Francisco, CA
February 16-19, 2010

Routine HIV Testing Proving Successful in Washington, DC

February 22, 2010

By Tim Horn

More HIV-positive residents of Washington, DC, are being tested and diagnosed earlier, entering into care faster and progressing to AIDS more slowly in recent years, according to data presented Wednesday, February 17, at the 17th Conference on Retroviruses and Opportunistic Infections (CROI). These encouraging findings likely speak to the effectiveness of an initiative launched by the DC Department of Health in 2006 to implement routine HIV testing with improved linkage to care throughout the city.

At least 3 percent of DC residents are infected with HIV, a total surpassing the 1 percent threshold constituting a “generalized or severe” epidemic, Amanda Castel, MD, MPH, of the George Washington University HIV/AIDS Institute and her colleagues reported at CROI. In light of DC’s burgeoning epidemic, the DC Department of Health launched an initiative in 2006 with several goals: to promote routine, opt-out HIV testing among health care providers; to encourage more people to get tested for HIV; and to connect more people with immediate care should they be diagnosed with HIV. The initiative was based on the revitalized testing guidelines of the U.S. Centers for Disease Control and Prevention (CDC).

For its analysis, Castel’s group assessed HIV/AIDS name-based surveillance data from January 2004 to December 2008, a timeframe that allowed the researchers to compare outcomes both before and after the 2006 campaign was launched.
In 2004, 19,766 HIV tests were performed in DC. With the start of the campaign in 2006, about 35,000 tests were performed. By 2008, the number of HIV tests performed jumped to 72,866—a 3.7-fold increase in the number of tests performed in DC of the five-year period.

There wasn’t a significant increase in the number of health care providers performing HIV tests—a primary goal of the increased testing initiative. Instead, health care providers who had been conducting HIV antibody simply conducted more of them in their practices. There was, however, an upswing in the number of community-based organizations and prisons conducting testing after the health department launched its 2006 outreach strategy.

There was a 17 percent increase in the number of new infections reported to the DC Department of Health after the revamped testing initiative went into effect. In 2004, for example, a total of 1,104 infections were reported; in 2007, the number was 1,296. The 2008 total of 1,100 is potentially incomplete due to delays in reporting.

The amount of time it took for a person to progress to AIDS after testing positive significantly slowed since 2004. Whereas 46.7 percent of new HIV cases progressed to AIDS within one year in 2004, 27.7 percent of HIV cased documented in 2008 progressed to AIDS within a year.

Linkage to care also improved dramatically, according to data highlighting the time between diagnosis and a first appointment with a health care provider for CD4 counts or viral load testing. Whereas only 66.7 percent of those newly diagnosed with HIV in 2004 received CD4 count or viral load testing within three months, the percentage increased to 80.2 percent in 2008. The proportion of patients who delayed entering care by more than 12 months after their diagnosis decreased from 23 percent in 2004 to 5.4 percent in 2008.

CD4 counts among those entering care for the first time were also likely to be higher after the 2006 program was implemented. In 2004, CD4 counts averaged 216 cells; by 2008, the average was 343 cells.

In conclusion, Castel said, “expanded routine HIV testing in Washington, DC, has been associated with an increased identification of HIV/AIDS cases and more rapid entry into care. Continued surveillance will help determine whether these findings will translate into improved clinical outcomes and reduced HIV transmissions.”

Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       

More from CROI 2010

HIV/AIDS Complications

March 9, 2010
HIV and the Brain: Part 2
March 8, 2010
Cancer Risks and HIV
HIV and the Brain: Part 1
March 1, 2010
HIV and Bone Health
February 25, 2010
Bone Fracture Risk Higher Among People Living With HIV
Vitamin D Deficiency Common Among HIV Positive
February 24, 2010
HIV in the Brain Usually Matches Levels in the Blood
Hep C Treatment Might Also Guard Against HIV Disease Progression
February 23, 2010
Truvada and Norvir-Boosted Reyataz More Likely to Cause Bone Loss in ACTG Study
Maintaining Higher CD4s Protects Against Brain Damage
February 20, 2010
HIV and Heart Disease Risks
February 19, 2010
Increased Risk of Chronic Kidney Disease Linked to Tenofovir and Atazanavir
Non-AIDS Cancer Risk Decreases With Higher CD4 Cell Counts
Smoking Cessation Reduces Cardiovascular Disease Risk in HIV
February 18, 2010
H1N1 Meets HIV
HIV Contributes to Lung Cancer Risk, but Not Nearly as Much as Smoking

HIV Transmission and Prevention

March 8, 2010
HIV Prevention: On the Verge of Success?
HIV Treatment in Southern Africa
March 1, 2010
One in Six New HIV Cases Involves Drug-Resistant Virus
February 22, 2010
Routine HIV Testing Proving Successful in Washington, DC
Testing and Treatment Tied to Fewer New HIV Cases in S.F. & Vancouver Studies

Starting and Switching Treatment

March 2, 2010
Normal Life Expectancy With Maintenance of CD4s Above 500
February 22, 2010
Testing and Treatment Tied to Fewer New HIV Cases in S.F. & Vancouver Studies
February 19, 2010
No Efficacy Differences in ACTG Study Comparing Sustiva or Reyataz with either Epzicom or Truvada
February 18, 2010
Once-Daily Prezista Effective, Safer for HIV Treatment-Experienced Patients

Experimental HIV Drugs

March 9, 2010
New Treatments for HIV: Part 1
New Treatments for HIV: Part 2
February 18, 2010
New CCR5 Antagonist Shows Promise in Early Study
Vicriviroc Falls Short in Treatment-Experienced HIV Studies
February 17, 2010
Quad Pill and Boosting Drug Show Well in Studies


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.